184.98 USD
+0.59 (+0.32%)
184.98 USD
0 (0%)
IRTC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. While IRTC seems to be doing ok healthwise, there are quite some concerns on its profitability. IRTC is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
IRTC had negative earnings in the past year.
In the past year IRTC had a positive cash flow from operations.
IRTC had negative earnings in each of the past 5 years.
In the past 5 years IRTC reported 4 times negative operating cash flow.
1.2 Ratios
With a decent Return On Assets value of -5.17%, IRTC is doing good in the industry, outperforming 65.95% of the companies in the same industry.
IRTC has a Return On Equity (-42.22%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.17% | ||
| ROE | -42.22% | ||
| ROIC | N/A |
ROA(3y)-22.19%
ROA(5y)-19.41%
ROE(3y)-77.27%
ROE(5y)-56.18%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
IRTC has a better Gross Margin (70.35%) than 78.92% of its industry peers.
In the last couple of years the Gross Margin of IRTC has declined.
IRTC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 70.35% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.34%
GM growth 5Y-1.83%
2. Health
2.1 Basic Checks
IRTC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IRTC has more shares outstanding
Compared to 5 years ago, IRTC has more shares outstanding
Compared to 1 year ago, IRTC has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.13 indicates that IRTC is not in any danger for bankruptcy at the moment.
IRTC has a better Altman-Z score (4.13) than 73.51% of its industry peers.
The Debt to FCF ratio of IRTC is 20.01, which is on the high side as it means it would take IRTC, 20.01 years of fcf income to pay off all of its debts.
IRTC has a better Debt to FCF ratio (20.01) than 70.27% of its industry peers.
A Debt/Equity ratio of 5.32 is on the high side and indicates that IRTC has dependencies on debt financing.
IRTC has a worse Debt to Equity ratio (5.32) than 84.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.32 | ||
| Debt/FCF | 20.01 | ||
| Altman-Z | 4.13 |
ROIC/WACCN/A
WACC9.59%
2.3 Liquidity
IRTC has a Current Ratio of 4.63. This indicates that IRTC is financially healthy and has no problem in meeting its short term obligations.
IRTC's Current ratio of 4.63 is fine compared to the rest of the industry. IRTC outperforms 75.14% of its industry peers.
A Quick Ratio of 4.50 indicates that IRTC has no problem at all paying its short term obligations.
IRTC's Quick ratio of 4.50 is fine compared to the rest of the industry. IRTC outperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.63 | ||
| Quick Ratio | 4.5 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 69.72% over the past year.
The Revenue has grown by 25.45% in the past year. This is a very strong growth!
The Revenue has been growing by 22.49% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)69.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.24%
Revenue 1Y (TTM)25.45%
Revenue growth 3Y22.39%
Revenue growth 5Y22.49%
Sales Q2Q%30.74%
3.2 Future
The Earnings Per Share is expected to grow by 23.66% on average over the next years. This is a very strong growth
Based on estimates for the next years, IRTC will show a quite strong growth in Revenue. The Revenue will grow by 18.45% on average per year.
EPS Next Y59.19%
EPS Next 2Y37.67%
EPS Next 3Y30.71%
EPS Next 5Y23.66%
Revenue Next Year26.1%
Revenue Next 2Y21.42%
Revenue Next 3Y19.47%
Revenue Next 5Y18.45%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for IRTC. In the last year negative earnings were reported.
Also next year IRTC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, IRTC is valued a bit cheaper than the industry average as 68.11% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 183.84 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
IRTC's earnings are expected to grow with 30.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.67%
EPS Next 3Y30.71%
5. Dividend
5.1 Amount
No dividends for IRTC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
184.98
+0.59 (+0.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners109.39%
Inst Owner Change0%
Ins Owners0.8%
Ins Owner Change-0.83%
Market Cap5.96B
Revenue(TTM)702.57M
Net Income(TTM)-51.46M
Analysts85.45
Price Target222.97 (20.54%)
Short Float %7.68%
Short Ratio5.16
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.57%
Min EPS beat(2)34.09%
Max EPS beat(2)81.05%
EPS beat(4)4
Avg EPS beat(4)55.92%
Min EPS beat(4)4.68%
Max EPS beat(4)103.85%
EPS beat(8)5
Avg EPS beat(8)0.84%
EPS beat(12)6
Avg EPS beat(12)-2.68%
EPS beat(16)10
Avg EPS beat(16)2.64%
Revenue beat(2)2
Avg Revenue beat(2)3.79%
Min Revenue beat(2)2.36%
Max Revenue beat(2)5.22%
Revenue beat(4)4
Avg Revenue beat(4)2.75%
Min Revenue beat(4)1.42%
Max Revenue beat(4)5.22%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)8
Avg Revenue beat(12)1.03%
Revenue beat(16)10
Avg Revenue beat(16)0.93%
PT rev (1m)-0.61%
PT rev (3m)19.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)146.19%
EPS NY rev (1m)0%
EPS NY rev (3m)20.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 8.48 | ||
| P/FCF | 183.84 | ||
| P/OCF | 80.67 | ||
| P/B | 48.9 | ||
| P/tB | 49.24 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.32
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)1.01
FCFY0.54%
OCF(TTM)2.29
OCFY1.24%
SpS21.81
BVpS3.78
TBVpS3.76
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.17% | ||
| ROE | -42.22% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 70.35% | ||
| FCFM | 4.61% |
ROA(3y)-22.19%
ROA(5y)-19.41%
ROE(3y)-77.27%
ROE(5y)-56.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.34%
GM growth 5Y-1.83%
F-Score6
Asset Turnover0.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.32 | ||
| Debt/FCF | 20.01 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 199.56% | ||
| Cap/Sales | 5.9% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.63 | ||
| Quick Ratio | 4.5 | ||
| Altman-Z | 4.13 |
F-Score6
WACC9.59%
ROIC/WACCN/A
Cap/Depr(3y)235.33%
Cap/Depr(5y)237.52%
Cap/Sales(3y)7.91%
Cap/Sales(5y)7.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.24%
EPS Next Y59.19%
EPS Next 2Y37.67%
EPS Next 3Y30.71%
EPS Next 5Y23.66%
Revenue 1Y (TTM)25.45%
Revenue growth 3Y22.39%
Revenue growth 5Y22.49%
Sales Q2Q%30.74%
Revenue Next Year26.1%
Revenue Next 2Y21.42%
Revenue Next 3Y19.47%
Revenue Next 5Y18.45%
EBIT growth 1Y44.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year154.25%
EBIT Next 3Y48.94%
EBIT Next 5Y33.14%
FCF growth 1Y158.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y442.85%
OCF growth 3YN/A
OCF growth 5YN/A
IRHYTHM TECHNOLOGIES INC / IRTC FAQ
What is the ChartMill fundamental rating of IRHYTHM TECHNOLOGIES INC (IRTC) stock?
ChartMill assigns a fundamental rating of 4 / 10 to IRTC.
Can you provide the valuation status for IRHYTHM TECHNOLOGIES INC?
ChartMill assigns a valuation rating of 2 / 10 to IRHYTHM TECHNOLOGIES INC (IRTC). This can be considered as Overvalued.
What is the profitability of IRTC stock?
IRHYTHM TECHNOLOGIES INC (IRTC) has a profitability rating of 2 / 10.
What is the expected EPS growth for IRHYTHM TECHNOLOGIES INC (IRTC) stock?
The Earnings per Share (EPS) of IRHYTHM TECHNOLOGIES INC (IRTC) is expected to grow by 59.19% in the next year.